United States · FDA National Drug Code directory
Montelukast Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-593_8bc013e8-5324-099d-e603-d78012b126bd
- Product NDC
- 55111-593
- Form
- TABLET, CHEWABLE
- Composition / generic term
- Montelukast Sodium
- Labeler
- Dr.Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120806
- Source listing expiry
- 20261231
Source-listed ingredients
- MONTELUKAST SODIUM — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, CHEWABLE in 1 BOTTLE (55111-593-05) · 55111-593-05
- 30 TABLET, CHEWABLE in 1 BOTTLE (55111-593-30) · 55111-593-30
- 10 BLISTER PACK in 1 CARTON (55111-593-78) / 10 TABLET, CHEWABLE in 1 BLISTER PACK (55111-593-79) · 55111-593-78
- 90 TABLET, CHEWABLE in 1 BOTTLE (55111-593-90) · 55111-593-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →